Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$720.3K
52.34K shares
What this filing means
BOBULSKY SUSAN plans to sell 52.34K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $720.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001950047-26-005668
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
52.34K
Shares to sell
$720.3K
Approx. market value
11K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
3/4/2022
1KPreviously Exercised Stock Options
Cash
1/25/2022
10KTotal acquired11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2022 | Restricted Stock Units N/A | 1K | — |
1/25/2022 | Previously Exercised Stock Options Cash | 10K | — |
| Total | 11K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
41.34K
Market value
$544.4K
3/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11K
Market value
$175.9K
6/4/2026
Total
Units
52.34K
Value
$720.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/11/2026 | 41.34K | $544.4K | — | Completed |
| Planned — Approximate Date | ||||
6/4/2026 | 11K | $175.9K | NASDAQ | Planned |
| Total | 52.34K | $720.3K | ||